140 related articles for article (PubMed ID: 16369225)
1. Gastroesophageal reflux disease and extraesophageal disease.
Katz PO
Rev Gastroenterol Disord; 2005; 5 Suppl 2():S31-8. PubMed ID: 16369225
[TBL] [Abstract][Full Text] [Related]
2. [When sour does not make merry at all . Fast relief for patients with reflux].
MMW Fortschr Med; 2003 Apr; 145(15):64. PubMed ID: 15104274
[No Abstract] [Full Text] [Related]
3. [Paradigm change in reflux disease. In reflux patients listening to is often more important than endoscopy].
MMW Fortschr Med; 2004 Nov; 146(45):60-1. PubMed ID: 15581111
[No Abstract] [Full Text] [Related]
4. [References for reflux therapy. Preventing nocturnal acid recurrence].
MMW Fortschr Med; 2003 Jul; 145(29-30):62. PubMed ID: 12958788
[No Abstract] [Full Text] [Related]
5. [Extraesophageal manifestations of gastroesophageal reflux disease].
Kim GH
Korean J Gastroenterol; 2008 Aug; 52(2):69-79. PubMed ID: 19077497
[TBL] [Abstract][Full Text] [Related]
6. [Graded therapy in reflux disease. "In severe cases 40 mg., in milder 20 mg."].
Gillessen A
MMW Fortschr Med; 2004 Mar; 146(11):54. PubMed ID: 15152771
[No Abstract] [Full Text] [Related]
7. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
Castell D; Bagin R; Goldlust B; Major J; Hepburn B
Aliment Pharmacol Ther; 2005 Jun; 21(12):1467-74. PubMed ID: 15948814
[TBL] [Abstract][Full Text] [Related]
8. [Stubborn reflux pain, inconspicuous esophagus. Which therapy brings the fastest relief?].
MMW Fortschr Med; 2004 Mar; 146(11):54. PubMed ID: 15152770
[No Abstract] [Full Text] [Related]
9. [Attention! Cough, asthma and Co. are often caused by reflux].
MMW Fortschr Med; 2004 Nov; 146(45):61. PubMed ID: 15581112
[No Abstract] [Full Text] [Related]
10. State of the art: extraesophageal manifestations of gastroesophageal reflux disease.
Katz PO
Rev Gastroenterol Disord; 2005; 5(3):126-34. PubMed ID: 16127347
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.
Wo JM; Koopman J; Harrell SP; Parker K; Winstead W; Lentsch E
Am J Gastroenterol; 2006 Sep; 101(9):1972-8; quiz 2169. PubMed ID: 16968502
[TBL] [Abstract][Full Text] [Related]
12. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].
Issing WJ; Tauber S; Folwaczny C; Reichel O
Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080
[TBL] [Abstract][Full Text] [Related]
13. Intravenous proton pump inhibitor therapy: a rationale for use.
Armstrong D
Rev Gastroenterol Disord; 2005; 5 Suppl 2():S18-30. PubMed ID: 16369224
[TBL] [Abstract][Full Text] [Related]
14. [The proton pump especially steady in grip. Fast help for nightly reflux complaints].
MMW Fortschr Med; 2003 Dec; 145(51-52):39. PubMed ID: 14974330
[No Abstract] [Full Text] [Related]
15. Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease.
Metz DC; Pratha V; Martin P; Paul J; Maton PN; Lew E; Pisegna JR
Am J Gastroenterol; 2000 Mar; 95(3):626-33. PubMed ID: 10710049
[TBL] [Abstract][Full Text] [Related]
16. [Reflux therapy in the elderly].
Krankenpfl J; 2005; 43(7-10):182. PubMed ID: 16515255
[No Abstract] [Full Text] [Related]
17. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.
Törüner M; Bektaş M; Cetinkaya H; Soykan I; Ozden A
Turk J Gastroenterol; 2004 Dec; 15(4):225-8. PubMed ID: 16249975
[TBL] [Abstract][Full Text] [Related]
18. [Gastroesophageal reflux involvement in ENT disorders].
Drug VL; Cobzeanu D; Papaghiuc C; Ciochină P; Gogălniceanu P; Bugioianoun C; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):220-2. PubMed ID: 16607774
[TBL] [Abstract][Full Text] [Related]
19. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
[TBL] [Abstract][Full Text] [Related]
20. Laryngopharyngeal reflux symptoms improve before changes in physical findings.
Belafsky PC; Postma GN; Koufman JA
Laryngoscope; 2001 Jun; 111(6):979-81. PubMed ID: 11404607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
